Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Peli Continues Enhancement of Cold Chain Industry

Published: Tuesday, April 23, 2013
Last Updated: Tuesday, April 23, 2013
Bookmark and Share
Company acquires renowned Minnesota Thermal Science, the industry leader of temperature controlled transportation products.

Peli Products, Inc. has announced the acquisition of Minnesota Thermal Science (MTS), the industry leader in global temperature controlled transportation products.

Based in Plymouth, Minnesota, MTS will merge with Peli’s already established BioPharma™ division.

“The combined entity will offer customers an even wider range of the most advanced temperature controlled packaging solutions for the safe transport of pharmaceuticals, tissue, biologics, diagnostics, blood and other healthcare products,” said Lyndon Faulkner, President and CEO of Peli.

Faulkner continued, “The award-winning thermal protection products of MTS will be matched with Peli’s global capabilities providing a worldwide solution of re-usable transportation and packaging products and services.”

In addition to Peli BioPharma cases that offer 140+ hours between 2.0 to 8.0C, customers will have access to the full suite of MTS products including the reusable Credo Cube®, which protects payload contents at defined temperatures longer than any other passive thermal shipper.

Equally impressive are the Credo Xtreme® full pallet which holds 890 litres and the half pallet which holds 406 litres, each providing 35 percent more payload space than the closest competitor.

In addition to their unique scientific packaging, MTS offers a complete range of services and software to support a reusable temperature controlled packaging solution.

“Joining forces with Peli will enable us to aim even higher and provide customers with an unmatched global cold chain solution under one company”, said Tom Anderson, CEO of MTS.

Anderson continued, “We’re confident that together we’ll deliver products and services to the industry better than any competitive offering. An accelerated product development programme which will significantly enhance the combined company’s solution set and associated cold chain services is already underway.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos